Trial Profile
Phase I/Ib Trial of Single Agent PBF-999 in Solid Tumour Advanced Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jan 2023
Price :
$35
*
At a glance
- Drugs PBF 999 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Palobiofarma
- 24 Jan 2023 Status changed from recruiting to completed.
- 12 Jan 2022 Planned End Date changed from 25 Feb 2022 to 30 Jun 2022.
- 12 Jan 2022 Planned primary completion date changed from 31 Dec 2021 to 30 Apr 2022.